Deraska, Peter V.
O’Leary, Colin
Reavis, Hunter D.
Labe, Shelby
Dinh, Tru-Khang
Lazaro, Jean-Bernard
Sweeney, Christopher
D’Andrea, Alan D. http://orcid.org/0000-0001-6168-6294
Kozono, David http://orcid.org/0000-0002-8916-396X
Article History
Received: 12 September 2017
Revised: 31 October 2017
Accepted: 13 November 2017
First Online: 7 February 2018
Competing interests
: CS is a co-founder of Leuchemix Inc., which is developing DMAPT as an anti-cancer agent. The remaining authors declare that they have no competing interests.